ALXN

Alexion Pharmaceuticals Inc
ALXN

Overview Fund Activity
Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

586 hedge funds and large institutions have $25.3B invested in Alexion Pharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 225 increasing their positions, 209 reducing their positions, and 95 closing their positions.

Holders
586
Holders Change
-9
Holders Change %
-1.51%
% of All Funds
13.31%
Holding in Top 10
17
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-10.53%
% of All Funds
0.39%
New
91
Increased
225
Reduced
209
Closed
95
Calls
$420M
Puts
$468M
Net Calls
-$48.2M
Net Calls Change
-$165M

Top Buyers

1
AAMU
1
Amundi Asset Management US
Massachusetts
$174M
2
Citadel Advisors
2
Citadel Advisors
Florida
$238M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$147M
4
Ameriprise
4
Ameriprise
Minnesota
$850M
5
Ninety One (UK)
5
Ninety One (UK)
United Kingdom
$84.1M

Top Sellers

1
BlackRock
1
BlackRock
New York
$2.15B
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$2.11B
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$2.51B
4
TP
4
Third Point
New York
$0
5
TCP
5
Tourbillon Capital Partners
New York
$71.6M
Name Market Value Shares Shares
Change 		Shares
Change %
AIS
676
Accurate Investment Solutions
Pennsylvania
– – -13 Closed
EA
677
Edge Advisors
Georgia
– – -3 Closed
CM
678
Caption Management
Oklahoma
– – – –
EFSCE
679
Enterprise Financial Services Corp (EFSC)
Missouri
$0 3 – –
AG
680
Artal Group
Luxembourg
– – – –
SM
681
Sabby Management
Florida
– – – –
MGIA
682
Moneta Group Investment Advisors
Missouri
$0 3 +3 New
NCM
683
Nelson Capital Management
California
$0 4 +4 New
LFA
684
Legacy Financial Advisors
Kentucky
$0 5 +5 New
24 25 26 27
28